custom image

Single Cell Biology

March 17-19, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change



Champion

About Novo Nordisk

At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.

Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone related disorders and obesity.

Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries.

 
Sust. Benefactor

AstraZeneca R&D High Level Overview:

We are driven by science, united by science, and every day, we push the boundaries of science to deliver life-changing medicines.

Link for more information: https://www.astrazeneca.com/r-...

Microbial Sciences:

Our business model thrives on being dynamic and partly externalized, with a firm focus on driving science in our key areas of interest. Early, flexible partnering with the brightest and best in the world allows us to combine knowledge and progress clinical development, while managing the challenges associated with neuroscience and microbial science research.

Link for more information: https://www.astrazeneca.com/r-...

CVRM:

We are committed to defining new standards of care for patients with cardiovascular disease, heart failure, metabolic diseases, such as diabetes and non-alcoholic steatohepatitis (NASH), and chronic kidney disease (CKD) - improving their outcomes and decreasing mortality rates.

Link for more information: https://www.astrazeneca.com/ou...

Respiratory / Immunology:

We are aiming to transform the treatment of respiratory diseases, with our growing portfolio of inhaled combinations at the core of care, biologics for the unmet needs of specific patient populations, and scientific advancements in disease modification.

Link for more information: https://www.astrazeneca.com/ou...

 
Sust. Benefactor

Cell Research is published by Springer Nature in partnership with the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences. Cell Research publishes original research results that are of unusual significance or broad conceptual or technical advances in all areas of life sciences, as long as the study is closely related to molecular and cell biology. In Cell Research the highly responsive editorial team provides a swift and professional service in support of submitting authors, ensuring high levels of author satisfaction. Cell Discovery is established in 2015 as a sister journal of the high profile international journal Cell Research. Cell Discovery publishes results of high significance and broad interest in all areas of molecular and cell biology.

 
Partner

DCVC Bio is a venture capital fund focused on early stage companies developing breakthrough technologies to develop new products in the life sciences: principally, agriculture, human therapeutics and industrial biotechnology. The firm looks for entrepreneurs that deploy deep technologies such as artificial intelligence, machine vision, robotics and autonomy, to develop smart platforms that produce multiple products directed at improving the human condition.